Comparison

YHO13177 European Partner

Item no. TMO-T4595-25mg
Manufacturer TargetMol
CASRN 912287-56-0
Amount 25mg
Category
Type Molecules
Specific against other
Purity 0,9864
Citations 1.Yamazaki R, et al. Novel acrylonitrile derivatives, YHO-13177 and YHO-13351, reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo. Mol Cancer Ther. 2011 Jul;10(7):1252-63.
Smiles COc1ccc(cc1OC)C(\C#N)=C\c2ccc(s2)N3CCC(O)CC3
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias YHO13177 , YHO 13177
Available
Short Description
YHO-13177 is a potent and specific inhibitor of BCRP; potentiated the cytotoxicity of SN-38 in cancer cells and no effect on P-glycoprotein–mediated paclitaxel resistance in MDR1-transduced human leukemia K562 cells.
Shipping
cool pack
Storage
-20°
Target names or alias
YHO13177 , YHO 13177
Molecular Weight
370, 47
Pathway
Membrane transporter/Ion channel
Target
BCRP

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close